May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Launching in a complex market? See how virtual tools can streamline consensus-building and optimize treatment planning in our latest customer story. Discover how we helped endocrinology KOLs achieve consensus on…
From interactive case studies to AI-driven avatars, our free webinar dives into the tools defining tomorrow’s life sciences education. Last spots available – sign up now!
Discover the unique pros and cons of in-person, hybrid, synchronous virtual, and asynchronous virtual meetings with our detailed infographic. Perfect for anyone planning efficient and engaging meetings, especially in pharmaceutical…
Unlock the potential of next-gen virtual tools in our upcoming webinar. From AI simulations to interactive AR booths, learn how to effectively apply these technologies in life sciences education and…
Transform challenges into opportunities with our new video series on creating vibrant company culture remotely. Learn how adopting a growth mindset can enhance your leadership and foster a thriving remote…
Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s remarkable to see the progress made in the technology compared to…
From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a staple in education and professional interaction. Embrace the future of collaboration today!
Dive into a comprehensive exploration of the latest trends and cutting-edge strategies in medical publication planning. Our exclusive webinar series, starting next week, offers a deep dive into the intricacies…
Explore our peer-reviewed article, “Considerations for Planning Effective and Appealing Advisory Boards and Other Small-Group Meetings with Health Care Providers: Importance of Participant Preferences.” Dive into key findings on HCPs’…
Discover how replacing in-person meetings with virtual alternatives can significantly cut carbon emissions and support environmental initiatives. Our latest video highlights the crucial role of virtual meetings in reducing the…
